BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Merck
US Department of Justice
Dow
UBS
Queensland Health
Accenture
McKesson
Daiichi Sankyo

Generated: January 23, 2018

DrugPatentWatch Database Preview

Dronabinol - Generic Drug Details

« Back to Dashboard

What are the generic sources for dronabinol and what is the scope of dronabinol freedom to operate?

Dronabinol
is the generic ingredient in three branded drugs marketed by Akorn Inc, Insys Therap, Svc Pharma, Abbvie, and Insys Dev Co Inc, and is included in five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Dronabinol has four patent family members in four countries.

There are eleven drug master file entries for dronabinol. Nine suppliers are listed for this compound.
Pharmacology for dronabinol
Ingredient-typeCannabinoids
Drug ClassCannabinoid
Medical Subject Heading (MeSH) Categories for dronabinol

US Patents and Regulatory Information for dronabinol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Insys Therap DRONABINOL dronabinol CAPSULE;ORAL 078501-001 Aug 19, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn Inc DRONABINOL dronabinol CAPSULE;ORAL 079217-002 Jun 20, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Insys Therap DRONABINOL dronabinol CAPSULE;ORAL 078501-003 Aug 19, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Svc Pharma DRONABINOL dronabinol CAPSULE;ORAL 078292-001 Jun 27, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Insys Dev Co Inc SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Insys Therap DRONABINOL dronabinol CAPSULE;ORAL 078501-002 Aug 19, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Svc Pharma DRONABINOL dronabinol CAPSULE;ORAL 078292-003 Jun 27, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Svc Pharma DRONABINOL dronabinol CAPSULE;ORAL 078292-002 Jun 27, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn Inc DRONABINOL dronabinol CAPSULE;ORAL 079217-001 Jun 20, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Insys Dev Co Inc SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for dronabinol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 ➤ Subscribe ➤ Subscribe
Abbvie MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 ➤ Subscribe ➤ Subscribe
Abbvie MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
McKesson
Moodys
Citi
Novartis
AstraZeneca
Cipla
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot